Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...
An estimated 80% of women have some type of menopause symptoms â€” and the more symptoms they experience, the greater the ...
A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.
Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.
Alzheimer’s disease is more common in women, and hormones like estrogen are believed to play a role in brain aging. Around ...